Showing results (211-220 of 373) with videos related to

Sort By:
Pageof 38
Journal of Genetic Counseling|September 13, 2006
Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: a pilot studyE A Lobb, P N Butow, A Moore, et al.
Patient Education and Counseling|September 13, 2001
Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancerB Meiser, P N Butow, A L Barratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2011
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendationsT Luckett, M T King, P N Butow, et al.
Cancer|August 15, 1987
Regional chemotherapy with the use of cisplatin and doxorubicin as primary treatment for advanced sarcomas in shoulder, pelvis, and thighF O Stephens, M H Tattersall, W Marsden, et al.
Cancer Genetics and Cytogenetics|February 1, 1987
Cytogenetic findings in cell lines derived from four ovarian carcinomasA Smith, C Roberts, C van Haaften-Day, et al.
Australian and New Zealand Journal of Medicine|October 1, 1995
Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancerJ A Levi, J M Beith, R D Snyder, et al.
International Journal of Cancer|February 15, 1989
Elevated apolipoprotein(a) levels in cancer patientsL C Wright, D R Sullivan, M Muller, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
Patient treatment preference in advanced breast cancer: a randomized cross-over study of doxorubicin and mitozantroneR Stuart-Harris, R J Simes, A S Coates, et al.
British Medical Journal (Clinical Research Ed.)|October 25, 1986
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancerR J Simes, M H Tattersall, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studiesJ A Levi, R M Fox, M H Tattersall, et al.
Pageof 38